{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T12:48:43Z","timestamp":1792586923640,"version":"4.5.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T00:00:00Z","timestamp":1771977600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.vaccine.2026.128409","type":"journal-article","created":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T13:40:49Z","timestamp":1772199649000},"page":"128409","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Preferences of Dutch pregnant women for RSV immunisation \u2013 a mixed method study"],"prefix":"10.1016","volume":"78","author":[{"given":"Emily W.E.M.","family":"Phijffer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charuja","family":"Sivakumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnes","family":"van den Hoogen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neeltje M.T.H.","family":"Crombag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marieke C.","family":"Punt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis J.","family":"Bont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kitty W.M.","family":"Bloemenkamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne G.","family":"Wildenbeest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2026.128409_bb0005","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJMoa2216480","article-title":"Bivalent Prefusion F vaccine in pregnancy to prevent RSV illness in infants","volume":"388","author":"Kampmann","year":"2023","journal-title":"New England J Med"},{"key":"10.1016\/j.vaccine.2026.128409_bb0010","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1016\/S0140-6736(22)00478-0","article-title":"Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis","volume":"399","author":"Li","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2026.128409_bb0015","series-title":"Pathogens","article-title":"Respiratory syncytial virus vaccines: a review of the candidates and the approved vaccines","volume":"12","author":"Topalidou","year":"2023"},{"key":"10.1016\/j.vaccine.2026.128409_bb0020","unstructured":"FDA Approves New Drug to Prevent RSV in Babies and Toddlers | FDA n.d. https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-new-drug-prevent-rsv-babies-and-toddlers (accessed February 7, 2024)."},{"key":"10.1016\/j.vaccine.2026.128409_bb0025","unstructured":"New medicine to protect babies and infants from respiratory syncytial virus (RSV) infection | European Medicines Agency n.d. https:\/\/www.ema.europa.eu\/en\/news\/new-medicine-protect-babies-and-infants-respiratory-syncytial-virus-rsv-infection (accessed February 7, 2024)."},{"key":"10.1016\/j.vaccine.2026.128409_bb0030","unstructured":"FDA Approves First Vaccine for Pregnant Individuals to Prevent RSV in Infants | FDA n.d. https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-first-vaccine-pregnant-individuals-prevent-rsv-infants (accessed February 7, 2024)."},{"key":"10.1016\/j.vaccine.2026.128409_bb0035","unstructured":"Abrysvo | European Medicines Agency n.d. https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/abrysvo (accessed February 7, 2024)."},{"key":"10.1016\/j.vaccine.2026.128409_bb0040","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1056\/NEJMoa1913556","article-title":"Single-dose Nirsevimab for prevention of RSV in preterm infants","volume":"383","author":"Griffin","year":"2020","journal-title":"New Engl J Med"},{"key":"10.1016\/j.vaccine.2026.128409_bb0045","unstructured":"Healthcare Providers: RSV immunization for children 19 months and younger | CDC n.d. https:\/\/www.cdc.gov\/vaccines\/vpd\/rsv\/hcp\/child.html (accessed February 7, 2024)."},{"key":"10.1016\/j.vaccine.2026.128409_bb0050","unstructured":"Caserta MT, O'leary ST, Munoz FM, Ralston SL. Palivizumab Prophylaxis in Infants and Young Children at Increased Risk of Hospitalization for Respiratory Syncytial Virus Infection. n.d."},{"key":"10.1016\/j.vaccine.2026.128409_bb0055","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJMoa2216480","article-title":"Bivalent prefusion F vaccine in pregnancy to prevent RSV illness in infants","volume":"388","author":"Kampmann","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2026.128409_bb0060","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S2352-4642(22)00321-2","volume":"7","author":"Sim\u00f5es","year":"2023","journal-title":"Lancet Child Adolesc Health"},{"key":"10.1016\/j.vaccine.2026.128409_bb0065","unstructured":"National institute for public health and the environment (RIVM). Vaccinatiegraad Rijksvaccinatieprogramma Nederland. Verslagjaar 2025 n.d. https:\/\/www.rivm.nl\/publicaties\/vaccinatiegraad-rijksvaccinatieprogramma-nederland-verslagjaar-2025 [accessed July 9, 2025]."},{"key":"10.1016\/j.vaccine.2026.128409_bb0070","unstructured":"REPORT OF THE SAGE WORKING GROUP ON VACCINE HESITANCY 12 November 2014* n.d."},{"key":"10.1016\/j.vaccine.2026.128409_bb0075","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.vaccine.2023.12.080","article-title":"Parental intention, attitudes, beliefs, trust and deliberation towards childhood vaccination in the Netherlands in 2022: indications of change compared to 2013","volume":"42","author":"Knijff","year":"2024","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.128409_bb0080","doi-asserted-by":"crossref","first-page":"4161","DOI":"10.1016\/j.vaccine.2015.04.036","article-title":"Vaccine hesitancy: definition, scope and determinants","volume":"33","author":"MacDonald","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.128409_bb0085","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.pedn.2022.03.010","article-title":"Parental vaccine hesitancy and concerns regarding the COVID-19 virus","volume":"65","author":"Salazar","year":"2022","journal-title":"J Pediatr Nurs"},{"key":"10.1016\/j.vaccine.2026.128409_bb0090","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.yapd.2022.03.011","article-title":"Vaccine hesitancy in pediatrics","volume":"69","author":"Lafnitzegger","year":"2022","journal-title":"Adv Pediatr"},{"key":"10.1016\/j.vaccine.2026.128409_bb0095","series-title":"Advies Immunisatie tegen RSV in het eerste levensjaar","author":"Gezondheidsraad","year":"2024"},{"key":"10.1016\/j.vaccine.2026.128409_bb0100","unstructured":"Peristat.nl n.d. https:\/\/www.peristat.nl\/ (accessed July 22, 2025)."},{"key":"10.1016\/j.vaccine.2026.128409_bb0105","unstructured":"Cijfers rondom zwanger en bevallen - KNOV n.d. https:\/\/www.knov.nl\/kennis-en-scholing\/vakkennis-en-wetenschap\/vakkennis\/cijfers-rondom-zwanger-en-bevallen (accessed July 22, 2025)."},{"key":"10.1016\/j.vaccine.2026.128409_bb0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0208601","article-title":"Beyond confidence: development of a measure assessing the 5C psychological antecedents of vaccination","volume":"13","author":"Betsch","year":"2018","journal-title":"PloS One"},{"key":"10.1016\/j.vaccine.2026.128409_bb0115","series-title":"Focus groups: A practical guide to applied research","author":"Krueger","year":"2014"},{"key":"10.1016\/j.vaccine.2026.128409_bb0120","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1177\/1098214005283748","article-title":"A general inductive approach for analyzing qualitative evaluation data","volume":"27","author":"Thomas","year":"2006","journal-title":"Am J Eval"},{"key":"10.1016\/j.vaccine.2026.128409_bb0125","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1191\/1478088706qp063oa","article-title":"Using thematic analysis in psychology","volume":"3","author":"Braun","year":"2006","journal-title":"Qual Res Psychol"},{"key":"10.1016\/j.vaccine.2026.128409_bb0130","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/intqhc\/mzm042","article-title":"Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups","volume":"19","author":"Tong","year":"2007","journal-title":"International J Qual Health Care"},{"key":"10.1016\/j.vaccine.2026.128409_bb0135","doi-asserted-by":"crossref","first-page":"S158","DOI":"10.1097\/INF.0000000000004632","article-title":"Protecting against respiratory syncytial virus an online questionnaire study exploring UK parents\u2019 acceptability of vaccination in pregnancy or monoclonal antibody Administration for Infants","volume":"44","author":"Paulson","year":"2025","journal-title":"Pediatric Infect Dis J"},{"key":"10.1016\/j.vaccine.2026.128409_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2025.127062","article-title":"Factors influencing acceptance of RSV immunization for newborns among pregnant individuals: a mixed-methods study","volume":"55","author":"Gagnon","year":"2025","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.128409_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2024.126541","article-title":"Respiratory syncytial virus (RSV) prevention: perception and willingness of expectant parents in the Netherlands","volume":"44","author":"Harteveld","year":"2025","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.128409_bb0150","unstructured":"RIVM vaccinatiegraad 2020 (2021) n.d."},{"key":"10.1016\/j.vaccine.2026.128409_bb0155","unstructured":"Childhood Vaccination Coverage Statistics, England, 2023\u201324 - NHS England Digital n.d. https:\/\/digital.nhs.uk\/data-and-information\/publications\/statistical\/nhs-immunisation-statistics\/england-2023-24 (accessed May 23, 2025)."},{"key":"10.1016\/j.vaccine.2026.128409_bb0160","unstructured":"Prenatal pertussis vaccination coverage in England from January to March 2024, and annual coverage for 2023 to 2024 - GOV.UK n.d. https:\/\/www.gov.uk\/government\/publications\/pertussis-immunisation-in-pregnancy-vaccine-coverage-estimates-in-england-october-2013-to-march-2014\/prenatal-pertussis-vaccination-coverage-in-england-from-january-to-march-2024-and-annual-coverage-for-2023-to-2024 (accessed May 23, 2025)."},{"key":"10.1016\/j.vaccine.2026.128409_bb0165","doi-asserted-by":"crossref","first-page":"7469","DOI":"10.1016\/j.vaccine.2023.11.013","article-title":"Maternal pertussis vaccination behavior: psychosocial, attitudinal and organizational factors","volume":"41","author":"Widdershoven","year":"2023","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.128409_bb0170","doi-asserted-by":"crossref","unstructured":"Widdershoven V, Reijs RP, Eskes A, Verhaegh-Haasnoot A, Hoebe CJPA. Acceptance of vaccination against pertussis, COVID-19 and influenza during pregnancy: a cross-sectional study. BMC Pregnancy Childbirth 2023;23. doi:https:\/\/doi.org\/10.1186\/s12884-023-05505-9.","DOI":"10.1186\/s12884-023-05505-9"},{"key":"10.1016\/j.vaccine.2026.128409_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2025.126790","article-title":"Pregnant women\u2019s choices for preventing respiratory syncytial virus (RSV)","volume":"48","author":"Wang","year":"2025","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.128409_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2025.127482","article-title":"An England-wide survey on attitudes towards antenatal and infant immunisation against respiratory syncytial virus amongst pregnant and post-partum women","volume":"62","author":"Broad","year":"2025","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.128409_bb0185","first-page":"1048","article-title":"Countering COVID-19 vaccine hesitancy in pregnancy: the 4 Cs","volume":"39","author":"Shook","year":"2021","journal-title":"Am J Perinatol"},{"key":"10.1016\/j.vaccine.2026.128409_bb0190","doi-asserted-by":"crossref","unstructured":"McCarron SA, Bradley DT, Hart ND. A scoping review of the reasons for and approaches to non-uptake of pertussis and influenza vaccinations in pregnant women in the United Kingdom and Ireland. BMC Pregnancy Childbirth 2023;23. doi:https:\/\/doi.org\/10.1186\/S12884-023-06171-7,.","DOI":"10.1186\/s12884-023-06171-7"},{"key":"10.1016\/j.vaccine.2026.128409_bb0195","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1186\/s13104-025-07291-3","article-title":"Assessment of effectiveness of health education bundle to overcome vaccine hesitancy in mothers: single blinded randomized study","volume":"18","author":"Bazar","year":"2025","journal-title":"BMC Res Notes"},{"key":"10.1016\/j.vaccine.2026.128409_bb0200","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1056\/NEJMoa2110275","article-title":"Nirsevimab for prevention of RSV in healthy late-preterm and term infants","volume":"386","author":"Hammitt","year":"2022","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.vaccine.2026.128409_bb0205","series-title":"Bijlage I Samenvatting van de productkenmerken - Abrysvo","author":"European Medicines Agency","year":"2023"},{"key":"10.1016\/j.vaccine.2026.128409_bb0210","unstructured":"Onderzoek toont redenen waarom zwangeren niet kiezen voor kinkhoestvaccinatie | NSPOH n.d. https:\/\/www.nspoh.nl\/actueel\/onderzoek-toont-redenen-waarom-zwangeren-niet-kiezen-voor-kinkhoestvaccinatie\/ (accessed July 23, 2025)."},{"key":"10.1016\/j.vaccine.2026.128409_bb0215","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1097\/INF.0000000000002384","article-title":"Attitudes of pregnant women and healthcare professionals toward clinical trials and routine implementation of antenatal vaccination against respiratory syncytial virus: a multicenter questionnaire study","volume":"38","author":"Wilcox","year":"2019","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2026.128409_bb0220","unstructured":"Kinderen krijgen | CBS n.d. https:\/\/www.cbs.nl\/nl-nl\/visualisaties\/dashboard-bevolking\/levensloop\/kinderen-krijgen (accessed February 10, 2026)."},{"key":"10.1016\/j.vaccine.2026.128409_bb0225","unstructured":"Huishoudens; kindertal, leeftijdsklasse kind, regio, 1 januari | CBS n.d. https:\/\/www.cbs.nl\/nl-nl\/cijfers\/detail\/71487ned?q=pariteit (accessed February 10, 2026)."},{"key":"10.1016\/j.vaccine.2026.128409_bb0230","unstructured":"Perined, Utrecht 2022."},{"key":"10.1016\/j.vaccine.2026.128409_bb0235","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.15585\/mmwr.mm7239a4","article-title":"Influenza, Tdap, and COVID-19 vaccination coverage and hesitancy among pregnant women \u2014 United States, April 2023","volume":"72","author":"Razzaghi","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2026.128409_bb0240","unstructured":"Prenatal pertussis vaccination coverage in England from January to March 2024, and annual coverage for 2023 to 2024 - GOV.UK n.d. https:\/\/www.gov.uk\/government\/publications\/pertussis-immunisation-in-pregnancy-vaccine-coverage-estimates-in-england-october-2013-to-march-2014\/prenatal-pertussis-vaccination-coverage-in-england-from-january-to-march-2024-and-annual-coverage-for-2023-to-2024 (accessed May 23, 2025)."},{"key":"10.1016\/j.vaccine.2026.128409_bb0245","doi-asserted-by":"crossref","first-page":"e2453696","DOI":"10.1001\/jamanetworkopen.2024.53696","article-title":"Uptake of maternal RSV vaccination and infant Nirsevimab among infants born October 2023 to march 2024","volume":"8","author":"Jacobson","year":"2025","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.vaccine.2026.128409_bb0250","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12889-024-18864-5","article-title":"Unmasking vaccine hesitancy and refusal: a deep dive into anti-vaxxer perspectives on COVID-19 in Spain","volume":"24","author":"Prieto-Campo","year":"2024","journal-title":"BMC Public Health"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26002173?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26002173?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T22:25:37Z","timestamp":1783376737000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X26002173"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":50,"alternative-id":["S0264410X26002173"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128409","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preferences of Dutch pregnant women for RSV immunisation \u2013 a mixed method study","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128409","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"128409"}}